Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stefano Bianchi is active.

Publication


Featured researches published by Stefano Bianchi.


Pacing and Clinical Electrophysiology | 2006

Prediction of response to cardiac resynchronization therapy: The selection of candidates for CRT (SCART) study

Augusto Achilli; Carlo Peraldo; Massimo Sassara; Serafino Orazi; Stefano Bianchi; Francesco Laurenzi; Roberto Donati; Giovanni B. Perego; Andrea Spampinato; Sergio Valsecchi; Alessandra Denaro; Andrea Puglisi

Background: The aim of this study was to evaluate the ability of baseline clinical and echocardiographic parameters to predict a positive response to CRT.


Journal of Cardiovascular Electrophysiology | 2008

Persistent Atrial Fibrillation Worsens Heart Rate Variability, Activity and Heart Rate, as Shown by a Continuous Monitoring by Implantable Biventricular Pacemakers in Heart Failure Patients

Andrea Puglisi; Maurizio Gasparini; M. Lunati; Massimo Sassara; Luigi Padeletti; Maurizio Landolina; Giovanni Luca Botto; Antonio Vincenti; Stefano Bianchi; Alessandra Denaro; Andrea Grammatico; Giuseppe Boriani

Background: Atrial fibrillation (AF) induces loss of atrial contribution, heart rate irregularity, and fast ventricular rate.


Circulation-cardiovascular Quality and Outcomes | 2012

Improving Thromboprophylaxis Using Atrial Fibrillation Diagnostic Capabilities in Implantable Cardioverter-Defibrillators The Multicentre Italian ANGELS of AF Project

Giuseppe Boriani; Massimo Santini; Maurizio Lunati; Maurizio Gasparini; Alessandro Proclemer; Maurizio Landolina; Luigi Padeletti; Giovanni Luca Botto; Alessandro Capucci; Stefano Bianchi; Mauro Biffi; Renato Ricci; Marco Vimercati; Andrea Grammatico; Gregory Y.H. Lip

Background— Atrial fibrillation (AF) is a well-established risk factor for stroke and thromboembolism and is a frequent comorbid arrhythmia in patients with implantable cardioverter-defibrillators (ICDs). The Anticoagulation Use Evaluation and Life Threatening Events Sentinels (ANGELS) of AF project was a medical care program aimed at supporting adherence to oral anticoagulation (OAC) guidelines for thromboprophylaxis through the use of ICD AF diagnostics. Methods and Results— Fifty Italian cardiology clinics followed 3438 patients with ICDs. In a subgroup of 15 centers (the ANGELS of AF centers), cardiologists attending to follow-up visits were supplied with specific reports describing stroke risk factors and risk scores (American College of Chest Physicians and CHADS2 [congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, and prior stroke or transient ischemic attack]), AF occurrence and duration, and current antithrombotic therapy for patients with AF, especially those with a CHADS2 score >0 and not on OAC therapy. The remaining centers represented a control group of patients as a comparison of OAC use. In the ANGELS of AF centers, 709 (36%) patients had AF described either in their clinical history (n=426 [22%]) or as new-onset AF (n=257 [14%]). Among 683 (96%) patients with CHADS2 score >0, 209 (30.6%) were not taking an OAC. Appropriate OAC therapy was prescribed in 10% (22/209) of patients after evaluation of ANGELS of AF reports. The percentage of patients on OAC therapy, as indicated by guidelines, increased during follow-up from 46.1% at baseline, to 69.4% at the stroke risk evaluation phase, to up to 72.6% at the end of the observation period. In control centers, corresponding figures were 46.9% at baseline and 56.8% at the end of the observation period (P<0.001 versus ANGELS of AF group). Conclusions— The ANGELS of AF project demonstrates the possibility to improve OAC use in accordance with available guidelines for stroke risk reduction in AF by supplying attending physicians with reports about patients risk factors and AF information from continuous ICD monitoring. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT01007474.


Journal of Cardiovascular Medicine | 2014

Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report.

Pietro Amedeo Modesti; Stefano Bianchi; Claudio Borghi; Matteo Cameli; Giovambattista Capasso; Antonio Ceriello; Marco Matteo Ciccone; Giuseppe Germano; Maria Maiello; Maria Lorenza Muiesan; Salvatore Novo; Luigi Padeletti; Pasquale Palmiero; Sergio Pillon; Carlo Maria Rotella; Pier Sergio Saba; Pietro Scicchitano; B. Trimarco; Massimo Volpe; Roberto Pedrinelli; Matteo Di Biase

Objectives To review information on cardiovascular health and migration, to stress the attention of researchers that much needs to be done in the collection of sound data in Italy and to allow policy makers identifying this issue as an important public health concern. Background In Italy, the rate of immigrants in the total number of residents increased from 2.5% in 1990 to 7.4% in 2010, and currently exceeds 10% in regions such as Lombardia, Emilia Romagna and Toscana. Methods A consensus statement was developed by approaching relevant Italian national scientific societies involved in cardiovascular prevention. Task force members were identified by the president and/or the boards of each relevant scientific society or working group, as appropriate. To obtain a widespread consensus, drafts were merged and distributed to the scientific societies for local evaluation and revision by as many experts as possible. The ensuing final draft was finally approved by scientific societies. Results In several western European countries, the prevalence of hypertension, diabetes, chronic kidney disease, obesity and metabolic syndrome was found to be higher among immigrants than in the native population. Although migrants are often initially healthier than non-migrant populations in their host countries, genetic factors, and changing environments with lifestyle changes, social exclusion and insufficient medical control may expose them to health challenges. Cultural reasons may also hamper both the dissemination of prevention strategies and migrant communication with healthcare providers. However, great diversity exists across and within different groups of migrants, making generalizations very difficult and many countries do not collect registry or survey data for migrants health. Conclusions In the present economic context, the European Union is placing great attention to improve data collection for migrant health and to support the implementation of specific prevention policies aimed at limiting the future burden of cardiovascular and renal disease, and the consequent load for health systems. Wider initiatives on the topic are awaited in Italy.


Pacing and Clinical Electrophysiology | 2004

Long-term effectiveness of dual site left ventricular cardiac resynchronization therapy in a patient with congestive heart failure.

Massimo Sassara; Augusto Achilli; Stefano Bianchi; Sabina Ficili; Antonino G.M. Marullo; Daniele Pontillo; Paola Achilli; Carlo Peraldo; Fabrizio Sgreccia

This article describes a case of cardiac resynchronization therapy (CRT) performed with dual site left ventricular pacing. The main clinical and functional long‐term results are in agreement with the most recent data regarding traditional CRT. Furthermore, this innovative pacing modality allowed optimal inter‐ and intraventricular resynchronization. (PACE 2004; 27[Pt. I]:805–807)


Journal of Cardiovascular Medicine | 2007

Results of the SCART study: selection of candidates for cardiac resynchronisation therapy.

Carlo Peraldo; Augusto Achilli; Serafino Orazi; Stefano Bianchi; Massimo Sassara; Francesco Laurenzi; Antonio Cesario; Gerardina Fratianni; Ernesto Lombardo; Sergio Valsecchi; Alessandra Denaro; Andrea Puglisi

Objective To prospectively determine whether prespecified electrocardiographic, echocardiographic and tissue Doppler imaging (TDI) selection criteria may predict a positive response to cardiac resynchronisation therapy (CRT). Methods In this multicentre, prospective, non-randomised study, 96 heart failure patients with New York Heart Association class III–IV symptoms, an ejection fraction of ≤35%, and at least one marker of ventricular dyssynchrony according to prespecified electrocardiographic, echocardiographic or TDI criteria were enrolled. The primary endpoint was an improvement in the clinical composite score at 6 months. Results At enrolment, 70 patients fulfilled the electrocardiographic criterion (QRS duration ≥150 ms), 77 patients showed echocardiographic signs of dyssynchrony, and 37 patients met the TDI dyssynchrony criteria. The overall responder rate was 78/96 (81%). In particular, the primary endpoint was reached in 68 patients who fulfilled the echocardiographic criteria as compared with 10 patients who did not (88 vs. 53%, P = 0.001). The patients who met the echocardiographic criteria showed a significant greater reduction in left ventricular end-systolic diameter (P = 0.029) and a higher improvement in quality of life (P = 0.017) than patients who did not. Neither electrocardiographic nor TDI criteria seemed to predict a positive response to CRT. Conclusions In our patient population, mechanical indexes of dyssynchrony as assessed by echocardiography appeared to identify CRT responders. Although TDI is useful for evaluating ventricular dyssynchrony after CRT, the prespecified TDI inclusion criteria adopted in this investigation did not increase the number of CRT responders.


Journal of Human Hypertension | 2013

Relationship between hypertension, diabetes and proteinuria in rural and urban households in Yemen

Pietro Amedeo Modesti; Mohamed Bamoshmoosh; Stefano Rapi; Luciano Massetti; Stefano Bianchi; Dawood Al-Hidabi; H Al Goshae

Little information is available on the meanings of proteinuria in low-resource settings. A population-based, cross-sectional survey was performed in Yemen on 10 242 subjects aged 15–69 years, stratified by age, gender and urban/rural residency. Hypertension is defined as systolic blood pressure (BP) of ⩾140 mm Hg and/or diastolic BP of ⩾90 mm Hg, and/or self-reported use of antihypertensive drugs; diabetes is diagnosed as fasting glucose of ⩾126 mg dl−1 or self-reported use of hypoglycaemic medications; proteinuria is defined as ⩾+1 at dipstick urinalysis. Odds ratios (ORs) for associations were determined by multivariable logistic regression models. Prevalence (weighted to the Yemen population aged 15–69 years) of hypertension, diabetes and proteinuria were 7.5, 3.7 and 5.1% in urban, and 7.8, 2.6 and 7.3% in rural locations, respectively. Proteinuria and hypertension were more prevalent among rural dwellers (adjusted ORs 1.56; 95% confidence limit (Cl) 1.31–1.86, and 1.23; 1.08–1.41, respectively), diabetes being less prevalent in rural areas (0.70; 0.58–0.85). Differently from hypertension and diabetes, proteinuria was inversely related with age. Most importantly, 4.6 and 6.1% of urban and rural dwellers, respectively, had proteinuria in the absence of hypertension and diabetes. The approach of considering kidney damage as a consequence of hypertension and diabetes might limit the effectiveness of prevention strategies in low-income countries.


European Heart Journal | 2004

Limited thoracotomy as a second choice alternative to transvenous implant for cardiac resynchronisation therapy delivery

Andrea Puglisi; Maurizio Lunati; Antonino G.M. Marullo; Stefano Bianchi; Mariano Feccia; Fabrizio Sgreccia; Ilaria Vicini; Sergio Valsecchi; Francesco Musumeci; Ettore Vitali


American Journal of Cardiology | 2007

Comparison of the Effects of Cardiac Resynchronization Therapy in Patients With Class II Versus Class III and IV Heart Failure (from the InSync/InSync ICD Italian Registry)†,‡

Maurizio Landolina; Maurizio Lunati; Maurizio Gasparini; Massimo Santini; Luigi Padeletti; Augusto Achilli; Stefano Bianchi; Francesco Laurenzi; Antonio Curnis; Antonio Vincenti; Sergio Valsecchi; Alessandra Denaro


International Journal of Cardiology | 2017

Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation

Mauro Biffi; Matteo Ziacchi; Renato Ricci; Domenico Facchin; Giovanni Morani; Maurizio Landolina; Maurizio Lunati; Saverio Iacopino; Alessandro Capucci; Stefano Bianchi; Tommaso Infusino; Giovanni Luca Botto; Luigi Padeletti; Giuseppe Boriani

Collaboration


Dive into the Stefano Bianchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Francesco Laurenzi

The Catholic University of America

View shared research outputs
Top Co-Authors

Avatar

Maurizio Lunati

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giuseppe Boriani

University of Modena and Reggio Emilia

View shared research outputs
Researchain Logo
Decentralizing Knowledge